Xueshuan Xinmaining Tablet is made from ten precious traditional Chinese medicines such as rhizome chuanxiong, leeches, toad venom, artificial musk, artificial bezoar, borneol, Panax Ginseng Leaves Extract. It has the efficacy of supplementing qi and activating blood circulation, inducing resuscitation and relieving pain. It is used for treating stroke and thoracic obstruction caused by qi deficiency and blood stasis, with symptoms of dizziness, hemiplegia, chest distress and shortness of breath; it is applicable to the patients with ischemic stroke convalescence, coronary heart disease, angina pectoris and the above syndromes. The drug was approved for marketing in 2003 and achieved good clinical results. Xueshuan Xinmaining Tablets was successfully selected as the "National Standardization Construction Demonstration Product" and became one of the two species shortlisted in the domestic cardiovascular and cerebrovascular field. In 2016, “Xueshuan Xinmaining Research on Key Technologies of Standardization and Industrialization" won the first prize of scientific and technological progress in Jilin Province. In 2018, Xueshuan Xinmaining Tablets achieved sales revenue of 200 million RMB.